* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slide 1
Polyadenylation wikipedia , lookup
List of types of proteins wikipedia , lookup
Silencer (genetics) wikipedia , lookup
Protein adsorption wikipedia , lookup
Gene regulatory network wikipedia , lookup
History of molecular evolution wikipedia , lookup
Molecular evolution wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Technology Licensing Opportunity Gene Bound Cationic Polymer Assemblies Based on Fully Degradable Carbonate Platform Keywords: (1) Self-assembled nanoparticles with potential for drug, protein and gene delivery (2) Biodegradable carbonate-based copolymers synthesized by organocatalytic ring-opening polymerization method Key Features • Lower cytotoxicity than many other polymers reported • Molecular weight & functionalities of the polymers can be easily controlled Background: Although PEI (Polyethylene imines) is recognized as a good nonviral vector with superior transfection efficiency due to high positive charge density to form compacted polyplexes as well as high density of near-neutral pka group for buffering, it is not biodegradable and considered highly cytotoxic. Hence, the major challenge in the design of synthetic transfection vectors is cationic polymers showing low cytotoxicity with spontaneously high transfection efficiency. The other cationic polymers, such as modified PEIs, poly(amino acid)s, poly(betaaminosulfonamide)s (PBASs), dendrimers based on poly(L-lysine) (PLL) and poly(amidoamine) (PAMAM) dendrimers have also been reported as efficient nonviral vectors for safe gene delivery. • Ease of scaling up Patents A patent application have been filed for this technology Key issues with these polymers are: (a)Broad distributed molecular weight (b)Difficulty in controlling molecular structure (c)High cost of production Publications Unpublished Commercialisation CF Polymer-gene complexation via electrostatic interactions is an effective trafficking Opportunities S R-(OH) and protection strategy for genetic materials, however, this tight packing also (i) O Technology is N CF N OHpresents a problem in the unpacking of genes H H O O available for HO O O licensing from The Invention: OBn O X Exploit The formation of a library of functional cyclic carbonate monomers and used in (ii) Technologies PteBnMPA 1 various combinations to provide polymers with both quaternary amine for Ltd. 1a; m = 3, X = Cl gene-binding, tertiary amines for buffering and functionalities to facilitate cargo 1b; m = 3. X = Br 1c; m = 2, X = I These polymers by organocatalytic ring-opening OHrelease. 1d; m =were 1, X =prepared H Contact Us HO O polymerization (ROP) that allows exquisite control over the molecular weight O Exploit R O O O OHand narrow polydispersities, and is tolerant to a variety of functional groups. Technologies O Private Limited Bis-MPA O N These polycarbonates for gene delivery have the following generic chemical (A member of N structure: A*STAR) 2a; m = 3, X = Cl, R 30 Biopolis Street, O O O 2b; m = 3. X = Br, R R #09-02 Matrix 2c; m = 2, X = I, R = O O O O O 2d; m = 3, X = Br, R Singapore 138671 O O 3a; m = 3, X = Cl, R Email: bms_techX 3b-L; m = 3. X = Br, O O N 3b-D; m = 3, X = Br, m~3 offer@exploitN 4, 5 tech.com 3 2 3 m~3 a b 2 + 4a; 4b; 4c; 4d; m m m m = = = = 3, 3. 2, 3, X X X X = = = = Cl, R = BnMPA, a : b = 0 : 1 Br, R = BnMPA, a : b = 0 : 1 I, R = BnMPA, a : b = 0 : 1 Br, R = BnMPA, a : b = 1 : 1 5a; m = 3, X = Cl, R = PTMC, a : b = 0 : 1 5b-L; m = 3. X = Br, R = PLLA, a : b = 0 : 1 5b-D; m = 3, X = Br, R = PDLA, a : b = 0 : 1 Disclaimer Although due care and attention have been taken to ensure that the preparation of this material is as accurate as possible, the contents of this brochure are provided for information purposes only. Neither the Agency for Science, Technology and Research, Exploit Technologies Pte Ltd nor the inventors offer any warranty, written expressed or implied, as to the accuracy of the said contents. Applicants are advised to undertake independent evaluation of the technology. Technology Licensing Opportunity Potential Applications: (1) Drug, gene and protein delivery The Advantages: (1) These polymers have lower cyctotoxicity than many other polymers reported in the literature (2) The molecular weight and functionalities of the polymers can be easily controlled, and the synthesis of these polymers can be readily scaled up in large quantities for preclinical and clinical trials Disclaimer Although due care and attention have been taken to ensure that the preparation of this material is as accurate as possible, the contents of this brochure are provided for information purposes only. Neither the Agency for Science, Technology and Research, Exploit Technologies Pte Ltd nor the inventors offer any warranty, written expressed or implied, as to the accuracy of the said contents. Applicants are advised to undertake independent evaluation of the technology.